Paul Tudor Jones II's position in Evolent Health is currently worth $6.92 Million. That's 0.06% of their equity portfolio (380th largest holding). The first Evolent Health trade was made in Q2 2015. Since then Paul Tudor Jones II bought shares eight more times and sold shares on nine occasions. The investor's estimated purchase price is $13.7 Million, resulting in a loss of 50%.